PD-L1 Expression Heterogeneity in NSCLC: Accuracy and Reliability of Using Primary Lung Tumour Versus Metastatic Lymph Node Deposits

被引：0
|
作者：
Haragan, A. K. [1 ]
Field, J. K. [2 ]
Davies, M. P. A. [2 ]
Escriu, C. [3 ]
Gruver, A. [4 ]
Gosney, J. R. [1 ]
机构：
[1] Univ Liverpool, Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
[2] Univ Liverpool, Liverpool, Merseyside, England
[3] Clatterbridge Oncol Ctr, Birkenhead, Merseyside, England
[4] Eli Lily & Co, Indianapolis, IN USA
来源：
JOURNAL OF PATHOLOGY | 2019年 / 248卷
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [21] PD-L1 expression on lung cancer stem cells in metastatic lymph nodes.
    Raniszewska, Agata
    Kwiecien, Iwona
    Polubiec-Kownacka, Malgorzata
    Rutkowska, Elzbieta
    Domagala-Kulawik, Joanna
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [22] Modeling tumour heterogeneity of PD-L1 expression in tumour progression and adaptive therapy
    Shizhao Ma
    Jinzhi Lei
    Xiulan Lai
    Journal of Mathematical Biology, 2023, 86
  • [23] Modeling tumour heterogeneity of PD-L1 expression in tumour progression and adaptive therapy
    Ma, Shizhao
    Lei, Jinzhi
    Lai, Xiulan
    JOURNAL OF MATHEMATICAL BIOLOGY, 2023, 86 (03)
  • [24] No Correlation between PD-L1 and NIS Expression in Lymph Node Metastatic Papillary Thyroid Carcinoma
    Bernadett, Levay
    Alexandra, Kiss
    Georgina, Froehlich
    Erika, Toth
    Andras, Slezak
    Ilona, Peter
    Ferenc, Oberna
    Orsolya, Dohan
    DIAGNOSTICS, 2024, 14 (17)
  • [25] PD-L1 expression in primary tumour vs metastatic samples in the phase III MYSTIC study in first-line metastatic (m) NSCLC
    Reinmuth, N.
    Boothman, A-M.
    Cho, B. C.
    Lee, K. H.
    Luft, A.
    Ahn, M-J.
    Scott, M.
    Whiteley, J.
    Walker, J.
    Karwe, V.
    Mukhopadhyay, P.
    Thiyagarajah, P.
    Scheuring, U.
    Rizvi, N.
    ANNALS OF ONCOLOGY, 2019, 30 : 611 - 611
  • [26] PD-L1 Expression in Primary Tumour vs Metastatic Samples in The Phase 3 MYSTiC Study in First-Line Metastatic (m) NSCLC
    Wehler, T.
    Reinmuth, N.
    Boothman, A. -M
    Cho, B. C.
    Lee, K. H.
    Luft, A.
    Ahn, M. -J.
    Scott, M.
    Whiteley, J.
    Walker, J.
    Karwe, V.
    Mukhopadhyay, P.
    Thiyagarajah, P.
    Scheuring, U.
    Rizvi, N.
    de Wit, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 120 - 120
  • [27] Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous Carcinoma
    Liu, Yiwei
    Dong, Zhengwei
    Jiang, Tao
    Hou, Likun
    Wu, Fengying
    Gao, Guanghui
    He, Yayi
    Zhao, Jing
    Li, Xuefei
    Zhao, Chao
    Zhang, Wei
    Tian, Qinrui
    Pan, Yingying
    Wang, Yan
    Yang, Shuo
    Wu, Chunyan
    Ren, Shengxiang
    Zhou, Caicun
    Zhang, Jun
    Hirsch, Fred R.
    CLINICAL LUNG CANCER, 2018, 19 (04) : E421 - E430
  • [28] The heterogeneity of PD-L1 expression among the different histological components and metastatic lymph nodes in patients with resected lung adenosquamous carcinoma
    Liu, Y.
    Ren, S.
    Yingying, P.
    Wu, C.
    Dong, Z.
    Wu, F.
    Tian, Q.
    Pan, Y.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2017, 28 : 119 - U474
  • [29] PD-L1 Expression of Paired Primary Resected Non Small Cell Carcinoma and Metastatic Lymph Node Fine Needle Aspirates
    Quinn, A. M.
    Bowden, R.
    Moss, A.
    Bloor, R.
    Harreld, C.
    Mcnulty, C.
    Montero, A.
    Crosbie, P.
    Blackhall, F.
    Summers, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S778 - S778
  • [30] PD-L1 in Primary Vulvar Cancer, Recurrences and Lymph Node Metastasis
    Lerias, Sofia
    Silvan, Fernanda
    Felix, Ana
    MODERN PATHOLOGY, 2019, 32
12345